Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-01-13

Clinical Trial Update: Type 2 Diabetes Primary Prevention for At Risk Girls [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial investigating primary prevention of Type 2 diabetes in at-risk girls has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Obesity, Diabetes Mellitus | Phase 2, Phase 3 | Status: COMPLETED